Trials / Completed

CompletedNCT01166633

Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia

A Randomized , Open Label, Dose Titration Study to Evaluate the Effect of Pitavastatin Versus Atorvastatin in Patients With Hypercholesterolemia and Mild to Moderate Hepatic Damage

Status: Completed
Phase: Phase 4
Study type: Interventional
Enrollment: 200 (actual)

Sponsor: JW Pharmaceutical · Industry
Sex: All
Age: 25 Years – 75 Years
Healthy volunteers: Accepted

Summary

Statin is an effective drug to treat hyperlipidemia (hypercholesterolemia), and it rarely leads to hepatic damage to the patients with hepatic disorder. For these patients, intensive monitoring is required.

Conditions

Hypercholesterolemia

Interventions

Type	Name	Description
DRUG	pitavastatin	pitavastatin 2mg per daily
DRUG	atorvastatin	atorvastatin 10mg per daily

Timeline

Start date: 2009-06-01
Primary completion: 2010-11-01
Completion: 2011-02-01
First posted: 2010-07-21
Last updated: 2022-04-11

Source: ClinicalTrials.gov record NCT01166633. Inclusion in this directory is not an endorsement.